PTPN1/2 Inhibition Remodels the Pulmonary Myeloid Landscape to Induce Alveolar Macrophage-Mediated Control of Lung Metastasis
{"Abstract":[0],"Metastasis":[1],"remains":[2],"the":[3,28,40,56,98,117],"leading":[4],"cause":[5],"of":[6,89,95,101,105,121],"cancer":[7],"mortality,":[8],"yet":[9],"effective":[10],"therapies":[11],"for":[12],"inhibiting":[13],"and":[14,71,74,84,86,112],"treating":[15],"metastasis":[16],"are":[17,21],"limited.":[18],"Therapeutic":[19],"responses":[20],"influenced":[22],"by":[23],"organ-specific":[24],"immune":[25,129],"microenvironments,":[26],"highlighting":[27],"need":[29],"to":[30,33,151],"develop":[31],"strategies":[32],"pharmacologically":[34,143],"modulate":[35],"these":[36],"niches.":[37],"Here,":[38],"using":[39],"clinical-stage":[41],"inhibitor":[42],"ABBV-CLS-484":[43],"(AC484)":[44],"as":[45,134],"a":[46,66,126,135,148],"chemical":[47],"probe,":[48],"we":[49],"demonstrated":[50],"that":[51,78,142],"systemic":[52],"PTPN1/2":[53,106,132],"inhibition":[54,104],"remodels":[55],"pulmonary":[57],"myeloid":[58],"landscape,":[59],"specifically":[60],"activating":[61],"alveolar":[62],"macrophages":[63,146],"(AMs)":[64],"toward":[65],"tumoricidal":[67],"state.":[68],"Integrated":[69],"single-cell":[70],"spatial":[72],"transcriptomics":[73],"functional":[75],"assays":[76],"revealed":[77],"AC484":[79],"promotes":[80],"accumulation,":[81],"IFNγ":[82],"production":[83],"responsiveness,":[85],"tumor-killing":[87],"activity":[88],"AMs":[90,96],"within":[91],"metastatic":[92,153],"lesions.":[93],"Depletion":[94],"diminished":[97],"anti-metastatic":[99],"efficacy":[100],"AC484.":[102,122],"Mechanistically,":[103],"amplified":[107],"IFNγ-STAT1":[108],"signaling":[109],"in":[110,156],"AMs,":[111],"disrupting":[113],"this":[114],"pathway":[115],"impaired":[116],"tumor":[118],"control":[119],"capability":[120],"These":[123],"findings":[124],"delineate":[125],"distinct":[127],"innate":[128],"axis":[130],"where":[131,158],"acts":[133],"molecular":[136],"\\"brake\\"":[137],"on":[138],"AM":[139],"activation,":[140],"suggesting":[141],"unleashing":[144],"tissue-resident":[145],"offers":[147],"therapeutic":[149],"strategy":[150],"overcome":[152],"progression,":[154],"particularly":[155],"microenvironments":[157],"adaptive":[159],"immunity":[160],"is":[161],"insufficient.":[162]}
Authors
- Nianxin Yang (ORCID: https://orcid.org/0000-0002-6842-7874)
- Nicole Fong (ORCID: https://orcid.org/0000-0002-1427-6716)
- David G. Hendrickson (ORCID: https://orcid.org/0000-0002-1884-5234)
- John Balibalos
- Kenneth J. Finn (ORCID: https://orcid.org/0009-0008-8223-915X)
- Marcia N. Paddock (ORCID: https://orcid.org/0000-0002-8350-1593)
- Jonathan D. Powell (ORCID: https://orcid.org/0000-0002-0850-2852)
- Leanne Jade G. Chan (ORCID: https://orcid.org/0000-0002-8825-6742)
- Jordan Brown (ORCID: https://orcid.org/0000-0001-9880-4784)
- Shagun Gupta (ORCID: https://orcid.org/0000-0002-4337-1413)
- Ka Man Li
- Varahram Shahryari
- P. Godfrey
- Evangelia Malahias
- Kayley Hake (ORCID: https://orcid.org/0000-0003-3310-1417)
- Im-Meng Sun
- J. Douglas O'Hara (ORCID: https://orcid.org/0000-0002-1139-1882)
- Lolita Penland
- Fiona E. McAllister (ORCID: https://orcid.org/0000-0002-7862-6711)
- Marc Creixell (ORCID: https://orcid.org/0000-0003-3981-934X)
- Aaron W. Stebbins
- Fiona Harding (ORCID: https://orcid.org/0000-0003-3817-1203)
- Po-Han Tai
- Yue Liu (ORCID: https://orcid.org/0000-0002-8344-9756)
- Jiaxi Wang (ORCID: https://orcid.org/0000-0001-6043-9953)
- Wenjun Kong (ORCID: https://orcid.org/0000-0001-5692-5609)
- James J. Lee (ORCID: https://orcid.org/0000-0001-6749-9350)
- Samir Kharbanda
- Chirag H. Patel
- Tuan Andrew. Nguyen (ORCID: https://orcid.org/0009-0000-1229-8949)
Institutions
- Enzo Life Sciences (United States) (US)
Publication Details
- Journal
- Cancer Research
- Published
- 2026-09-15
- DOI
- https://doi.org/10.1158/0008-5472.can-26-0770
- Primary Topic
- Protein Tyrosine Phosphatases
- Type
- article
- Field-Weighted Citation Impact
- 0.00